Medicure Announces Settlement of Holdback Dispute from Apicore Sale

WINNIPEG, Dec. 5, 2019 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company”) (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, today announced that it has reached a settlement agreement with the purchaser of Medicure’s interests in Apicore with respect to the amounts…

About the Author

has written 41552 stories on this site.

Copyright © 2010 Business and Corporate News.